loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 75276 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 BETAMETHASONE DIPROPIONATE (1)

filter

01 FOUGERA PHARMS (1)

filter

01 GEL, AUGMENTED;TOPICAL (1)

filter

01 EQ 0.05% BASE (1)

filter

01 USA (1)

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
GEL, AUGMENTED;TOPICAL
EQ 0.05% BASE
BETAMETHASONE DIPROPIO...
USA
75276
2003-05-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 75276

Looking for CTD TGA MCC DOSSIER APPLICATION 75276 1

19

Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is BETAMETHASONE DIPROPIONATE, with a corresponding application number 75276 and regulatory information .

proudly manufactured in the

approval since 2003-05-13

Fougera Pharmaceuticals Inc.'s BETAMETHASONE DIPROPIONATE GEL, AUGMENTED;TOPICAL, medication with EQ 0.05% BASE of BETAMETHASONE DIPROPIONATE.

Post Enquiry
POST ENQUIRY